HK1024932A1 - Mammalian cytokine: interleukin-b30 and related reagents - Google Patents

Mammalian cytokine: interleukin-b30 and related reagents

Info

Publication number
HK1024932A1
HK1024932A1 HK00103140.3A HK00103140A HK1024932A1 HK 1024932 A1 HK1024932 A1 HK 1024932A1 HK 00103140 A HK00103140 A HK 00103140A HK 1024932 A1 HK1024932 A1 HK 1024932A1
Authority
HK
Hong Kong
Prior art keywords
interleukin
related reagents
mammalian cytokine
cytokine
mammalian
Prior art date
Application number
HK00103140.3A
Other languages
English (en)
Inventor
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1024932(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1024932A1 publication Critical patent/HK1024932A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00103140.3A 1997-07-25 2000-05-26 Mammalian cytokine: interleukin-b30 and related reagents HK1024932A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Publications (1)

Publication Number Publication Date
HK1024932A1 true HK1024932A1 (en) 2000-10-27

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103140.3A HK1024932A1 (en) 1997-07-25 2000-05-26 Mammalian cytokine: interleukin-b30 and related reagents

Country Status (29)

Country Link
EP (3) EP1002084B1 (cs)
JP (5) JP4316133B2 (cs)
KR (1) KR100666835B1 (cs)
CN (2) CN101851286A (cs)
AR (2) AR017510A1 (cs)
AT (1) ATE443142T1 (cs)
AU (1) AU741046B2 (cs)
BR (1) BR9811039A (cs)
CA (1) CA2296272C (cs)
CO (1) CO4810232A1 (cs)
CZ (1) CZ300958B6 (cs)
DE (1) DE69841161D1 (cs)
DK (2) DK2100959T3 (cs)
ES (2) ES2331762T3 (cs)
HK (1) HK1024932A1 (cs)
HU (1) HU230629B1 (cs)
ID (1) ID28114A (cs)
IL (3) IL134068A0 (cs)
LT (1) LT2100959T (cs)
MY (1) MY157028A (cs)
NO (1) NO329329B1 (cs)
NZ (1) NZ502391A (cs)
PE (1) PE20000183A1 (cs)
PL (1) PL197150B1 (cs)
PT (2) PT1002084E (cs)
SK (1) SK287198B6 (cs)
TW (1) TWI237057B (cs)
WO (1) WO1999005280A1 (cs)
ZA (1) ZA986596B (cs)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
WO1999020652A1 (fr) * 1997-10-23 1999-04-29 Nippon Institute For Biological Science Facteur stimulant les colonies de granulocytes de felins
WO1999040195A1 (en) * 1998-02-06 1999-08-12 Schering Corporation Mammalian receptor proteins; related reagents and methods
EP1072610B1 (en) 1998-04-14 2010-07-21 Chugai Seiyaku Kabushiki Kaisha Novel cytokine-like protein
EP3184637A1 (en) 1999-09-09 2017-06-28 Merck Sharp & Dohme Corp. Mammalian interleukin-12 p40 and interleukin b30 complexes, antibodies, uses in pharmaceutical compositions
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
CA2388562C (en) * 1999-09-09 2014-07-22 Schering Corporation Mammalian cytokines; related reagents and methods
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
JP5477998B2 (ja) 2002-10-30 2014-04-23 ジェネンテック， インコーポレイテッド Ｉｌ−１７産生の阻害
AU2004239288B2 (en) 2003-05-09 2010-01-28 Centocor, Inc. IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
US7491391B2 (en) 2005-06-30 2009-02-17 Centocor, Inc. Anti-IL-23 antibodies, compositions, methods and uses
ES2622602T3 (es) 2005-12-29 2017-07-06 Janssen Biotech, Inc. Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
CA2655372A1 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
AU2008328785A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
CA2721713C (en) 2008-05-05 2019-07-09 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
MX2011011729A (es) 2009-05-05 2012-04-10 Novimmune Sa Anticuerpo anti il-17f y metodos de uso de los mismos.
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
MX2019000046A (es) 2010-11-04 2023-10-05 Boehringer Ingelheim Int Anticuerpos anti-il-23.
CA2871985C (en) 2012-05-03 2023-10-10 Boehringer Ingelheim International Gmbh Anti-il-23p19 antibodies
EA201591579A1 (ru) 2013-03-15 2016-01-29 Амген Инк. Способы лечения болезни крона при помощи анти-il-23 антитела
WO2014149425A1 (en) 2013-03-15 2014-09-25 Amgen Inc. Methods for treating psoriasis using an anti-il-23 antibody
US10507241B2 (en) 2014-07-24 2019-12-17 Boehringer Ingelheim International Gmbh Biomarkers useful in the treatment of IL-23A related diseases
UA123624C2 (uk) 2014-09-03 2021-05-05 Бьорінґер Інґельхайм Інтернаціональ Ґмбх Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
AU2016379157A1 (en) 2015-12-22 2018-06-21 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists
KR20210032441A (ko) 2018-07-13 2021-03-24 아스트라제네카 콜라보레이션 벤처스, 엘엘씨 브라지쿠맙을 이용한 궤양성 대장염의 치료
BR112021009287A2 (pt) 2018-11-20 2021-10-26 Janssen Biotech, Inc. Método seguro e eficaz para tratar psoríase com anticorpo específico anti-il-23
JP2022534020A (ja) 2019-05-23 2022-07-27 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
KR20220143005A (ko) 2019-12-20 2022-10-24 노바록 바이오테라퓨틱스 리미티드 항-인터루킨-23 p19 항체 및 이의 사용 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319315A (en) 1969-06-19 1973-06-06 Citizen Watch Co Ltd Calendar timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
EP1072610B1 (en) * 1998-04-14 2010-07-21 Chugai Seiyaku Kabushiki Kaisha Novel cytokine-like protein

Also Published As

Publication number Publication date
LT2100959T (lt) 2017-01-10
CZ2000263A3 (cs) 2000-06-14
EP2100959A3 (en) 2009-10-14
DK2100959T3 (en) 2017-01-30
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
IL205765A0 (en) 2011-07-31
DE69841161D1 (de) 2009-10-29
JP2010011863A (ja) 2010-01-21
JP2013034480A (ja) 2013-02-21
EP1002084A1 (en) 2000-05-24
PL197150B1 (pl) 2008-03-31
NZ502391A (en) 2002-12-20
IL134068A0 (en) 2001-04-30
CN1271387A (zh) 2000-10-25
AR017510A1 (es) 2001-09-12
ES2610483T3 (es) 2017-04-27
CA2296272A1 (en) 1999-02-04
PE20000183A1 (es) 2000-03-11
IL205765A (en) 2015-07-30
ATE443142T1 (de) 2009-10-15
AU8589498A (en) 1999-02-16
CA2296272C (en) 2012-03-13
ES2331762T3 (es) 2010-01-14
TWI237057B (en) 2005-08-01
EP2100959A2 (en) 2009-09-16
MY157028A (en) 2016-04-15
JP4316133B2 (ja) 2009-08-19
PT1002084E (pt) 2009-12-16
DK1002084T3 (da) 2010-01-04
IL134068A (en) 2010-11-30
PT2100959T (pt) 2017-01-09
BR9811039A (pt) 2000-08-08
SK912000A3 (en) 2000-09-12
JP2015037405A (ja) 2015-02-26
HU230629B1 (hu) 2017-04-28
ID28114A (id) 2001-05-03
PL338262A1 (en) 2000-10-09
KR20010022214A (ko) 2001-03-15
AU741046B2 (en) 2001-11-22
WO1999005280A1 (en) 1999-02-04
HUP0004019A3 (en) 2003-08-28
SK287198B6 (sk) 2010-03-08
HUP0004019A2 (en) 2001-03-28
JP2001511347A (ja) 2001-08-14
KR100666835B1 (ko) 2007-01-11
NO20000343D0 (no) 2000-01-24
JP2005323610A (ja) 2005-11-24
NO329329B1 (no) 2010-09-27
EP2100959B1 (en) 2016-12-07
ZA986596B (en) 1999-02-08
AR086483A2 (es) 2013-12-18
CO4810232A1 (es) 1999-06-30
CN101851286A (zh) 2010-10-06
CZ300958B6 (cs) 2009-09-23
NO20000343L (no) 2000-03-24

Similar Documents

Publication Publication Date Title
HUP0004019A2 (en) Mammalian cytokine: interleukin-b30 and related reagents
AU7103198A (en) Mammalian cytokines; related reagents and methods
IL148300A0 (en) Mammalian cytokines; related reagents and methods
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
GB9720148D0 (en) Gene silencing materials and methods
AU6700598A (en) Intron-mediated recombinant techniques and reagents
AU8173098A (en) Neuroprotective methods and reagents
EP1005479A4 (en) RNS INSULATION REAGENT AND METHOD
GB9705903D0 (en) VP22 Proteins and uses thereof
GB9727172D0 (en) Reagents specific for st2l and uses therefor
IL133582A0 (en) Mammalian neuro-growth factor like protein
IL126923A0 (en) Mammalian tolloid-like gene and protein
GB9701710D0 (en) Mammalian protein
IL136988A0 (en) Novel nucleic acid and polypeptide
GB9713666D0 (en) Biosensor materials and methods
GB9704162D0 (en) Assay methods and means
GB9417793D0 (en) Bioluminescence and assay reagents
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
AU1664299A (en) Autodegradable microcarriers and their use
PL341293A1 (en) Beta-lypothropin and application thereof
AU7959598A (en) Mammalian melanocortin receptors and uses
IL136693A0 (en) V196 dna and polypeptides
AU6258399A (en) Intron-mediated recombinant techniques and reagents
GB0120368D0 (en) Assays therapeutic methods and means
AU6762398A (en) Mammalian cytokine receptor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160724